Skip to main content
Clinical Trials/NCT03717636
NCT03717636UnknownNot Applicable

Prospective and Randomized Comparative Analysis, Between Early or Non-revoked in Day Hospital in Patients With Acute Heart Failure

University of Sao Paulo General Hospital1 site in 1 country720 target enrollmentStarted: October 1, 2018Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
720
Locations
1
Primary Endpoint
Comparison of 30-days rehospitalization rate

Study Overview

Brief Summary

Heart failure is one of the major causes of hospitalization in Brazil and worldwide. Recent studies attempt to identify readmission and prognostic markers at the time of discharge from these patients. The reassessment and possibility of early therapeutic adjustment may be relevant in this context. Therefore, the prospective and randomized comparative use of early re-evaluation in Hospital-day versus non-intervention group has not yet been described. The objective of this study was to evaluate the impact on the re-hospitalization rate in 30 days of the early re-evaluation of the patients in the day-hospital versus the non-intervention group in heart failure. For this, a unicentric, randomized and prospective study will be performed, in which the Hospital-Day strategy is performed versus no intervention in a comparative manner. Hospital data (test results, medical outcomes, complications) of patients will be analyzed for safety and effectiveness. The hypothesis of this study is that the Hospital-Day strategy is superior to the non-intervention strategy and causes fewer rehospitalizations within 30 days.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Adult men and women aged> 18 years.
  • •Presence of decomposed CF III or IV of NYHA characterized by> 1 symptom (dyspnea, orthopnea or edema) + 1 clinical sign (rales, edema, ascites or pulmonary congestion on chest X-ray).
  • •LVEF <45% on transthoracic echocardiography.
  • •BNP> 400 pg / mL.
  • •Clinical condition of hospital discharge.
  • •Signed consent form.

Exclusion Criteria

  • •Pregnancy
  • •Body mass index greater than 40 kg / m
  • •Chronic obstructive pulmonary disease.
  • •Acute coronary syndrome.
  • •Acute myocarditis.
  • •Valvular heart disease.
  • •Need to use vasoactive drug.
  • •Cirrhosis of the liver Child C.
  • •Chronic dialysis renal insufficiency or creatinine> 3.0 mg / dL.
  • •Indication of implantation device of artificial stimulation.
  • •Pulmonary thromboembolism.
  • •Neoplasm terminal.
  • •Sepsis or septic shock.

Arms & Interventions

Hospital Day

Experimental

Patients in the Hospital-Day group will return for medical evaluation 7-14 days in the specific unit.

Intervention: medical evaluation (Other)

Outpatient clinic

Other

The patients in control group will return for medical evaluation 30 days at the outpatient clinic.

Intervention: medical evaluation (Other)

Outcomes

Primary Outcomes

Comparison of 30-days rehospitalization rate

Time Frame: 30 days

30-days rehospitalization rate

Secondary Outcomes

  • Mortality(30 days)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials